<DOC>
	<DOCNO>NCT01616537</DOCNO>
	<brief_summary>Background Patient satisfaction acceptance care assessment increasingly take account oncology . Most cancer critically-ill patient require totally-implanted Central Venous Catheter ( CVC ) treatment consist reservoir connect central venous catheter , may may valved . It impossible estimate number CVC use oncology . However , author claim , 2005 , 7 million CVCs place United States chronic acute care . Although many patient fit CVC able undertake activity hinder external vascular access device , often physically psychologically anxious device . To knowledge , validated questionnaire measure patient acceptance satisfaction CVC report literature . Based observation , aim study develop validate French-language questionnaire dub QASICC ( Questionnaire Acceptance Satisfaction Implanted Central Venous Catheter ) assess patient satisfaction acceptance CVC . QASICC design multi-dimensional , self-administered questionnaire comprise approximately 30 item relate use , appearance pro con device well quality life perceive patient use one treatment . Objective The purpose study validate French-language self-administered questionnaire ( QASICC ) design evaluate patient ' satisfaction acceptance concern totally-implanted central venous catheter : confirmatory validation questionnaire psychometric property . Study Design This prospective , multicenter , open study . Primary Outcome Measures : Questionnaire 's 27 item test 990 patient confirm QASICC internal structure : - Items quality - Dimensional structure - Dimensional consistence - Measure accuracy - Measure reliability - Sensitivity change</brief_summary>
	<brief_title>Evaluation Patient Satisfaction With Acceptance Their Totally-implanted Central Venous Catheter</brief_title>
	<detailed_description>QASICC Questionnaire The QASICC questionnaire include 27 question ( Q ) assess seven dimension : pain placement use ( Q1 , Q2 ) , contribution comfort treatment ( Q3 , Q4 , Q7 , Q10 , Q12 ) , esthetic privacy ( Q5 , Q6 , Q8 , Q11 , Q17 , Q19 ) , impact professional activity , social sport ( Q9 , Q13 , Q14 , Q18 , Q20 ) , impact daily activity ( Q15 , Q16 , Q21 , Q22 ) , local discomfort ( Q23 , Q24 , Q25 , Q26 ) overall satisfaction ( Q27 ) . The device-related answer two type : Likert visual analogue scale . Four type Likert response available : `` '' , `` low , '' `` moderate , '' `` significant , '' / '' never , '' `` sometimes , '' `` often , '' `` always `` / '' easy `` , '' easy `` , '' difficult `` , '' difficult `` / '' `` , '' somewhat `` , '' lot `` , '' extremely `` . These question score 0 , 33 , 67 , 100 , respectively , score correlate symptom , 100 , 67 , 33 , 0 score inversely correlate symptom . Visual analog scale ( VAS ) length 100 mm . The score represent number mm measure scale . A mean score acceptance satisfaction calculate scale 0 100 seven dimension use follow formula : { ( 100-score DO ) + CO + score ( score ES-100 ) + ( 100-PR score ) + ( 100-ES score ) + ( score 100-IN ) + SA score } / 7 . The high overall score , great acceptance satisfaction The questionnaire administer patient 30 day ( +/-7 day ) CVC implantation .</detailed_description>
	<mesh_term>Mast-Cell Sarcoma</mesh_term>
	<mesh_term>Mastocytoma</mesh_term>
	<criteria>18 year old Patient benefit benefit implantation CVC Solid tumor hematologic malignancy WHO Performance Status 02 Any severe psychopathological disorder prevent completion questionnaire invalidate questionnaire 's measure Severe depressive state Non malignant pathology Inability respond questionnaire Patient speak fluent French Patient unable consent Patient guardianship</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>solid tumor</keyword>
	<keyword>hematological malignancy</keyword>
</DOC>